• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.

作者信息

Braga Catherine C, Taplitz Randy A, Flowers Christopher R

机构信息

1 Emory University Hospital, Atlanta, GA.

出版信息

J Oncol Pract. 2019 Jan;15(1):25-26. doi: 10.1200/JOP.18.00718.

DOI:10.1200/JOP.18.00718
PMID:30629901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333383/
Abstract
摘要

相似文献

1
Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.发热性中性粒细胞减少症指南在癌症患者群体中的临床意义。
J Oncol Pract. 2019 Jan;15(1):25-26. doi: 10.1200/JOP.18.00718.
2
[Febrile neutropenia in cancer patients: management in the emergency room].[癌症患者的发热性中性粒细胞减少症：急诊室的管理]
Rev Chilena Infectol. 2018;35(1):62-71. doi: 10.4067/s0716-10182018000100062.
3
Critical appraisal of clinical practice guidelines for adult cancer patients with febrile neutropenia.对成人发热性中性粒细胞减少症癌症患者临床实践指南的批判性评价。
Int J Pharm Pract. 2018 Feb;26(1):49-54. doi: 10.1111/ijpp.12357. Epub 2017 Mar 27.
4
History and outcome of febrile neutropenia related to non-chemotherapy drugs: A retrospective study of the Strasbourg's agranulocytosis cohort.非化疗药物相关发热性中性粒细胞减少症的病史及转归：对斯特拉斯堡粒细胞缺乏症队列的一项回顾性研究
Eur J Intern Med. 2017 Dec;46:e13-e14. doi: 10.1016/j.ejim.2017.08.018. Epub 2017 Aug 18.
5
Optimal Management of Neutropenic Fever in Patients With Cancer.癌症患者中性粒细胞减少性发热的最佳管理。
J Oncol Pract. 2019 Jan;15(1):19-24. doi: 10.1200/JOP.18.00269.
6
[Management of febrile neutropenia in cancer patients].[癌症患者发热性中性粒细胞减少症的管理]
Rev Med Liege. 2015 Apr;70(4):195-200.
7
Morbidity and mortality revisited: applying a new quality improvement paradigm in oncology.重新审视发病率和死亡率：在肿瘤学中应用新的质量改进范式。
J Oncol Pract. 2015 May;11(3):e428-33. doi: 10.1200/JOP.2014.003566. Epub 2015 Apr 21.
8
Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.癌症化疗期间发热伴中性粒细胞减少症患者使用抗生素的时间与临床结局的关系：系统评价。
Support Care Cancer. 2020 Mar;28(3):1369-1383. doi: 10.1007/s00520-019-04961-4. Epub 2019 Jul 1.
9
Can mortality of cancer patients with fever and neutropenia be improved?发热伴中性粒细胞减少的癌症患者的死亡率能得到改善吗？
Curr Opin Infect Dis. 2015 Dec;28(6):505-13. doi: 10.1097/QCO.0000000000000202.
10
Appraising of the Clinical Practice Guidelines Quality in the Non-Pharmacological Management of Chemotherapy-Induced Febrile Neutropenia; A Review.化疗引起的发热性中性粒细胞减少症非药物管理临床实践指南质量评估；综述
Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2701-2707. doi: 10.22034/APJCP.2018.19.10.2701.

引用本文的文献

1
Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumors.影响发热性中性粒细胞减少症患者住院时间的因素：对土耳其实体瘤患者的一项回顾性队列研究
Medicine (Baltimore). 2025 Jul 4;104(27):e43105. doi: 10.1097/MD.0000000000043105.
2
Investigation of antimicrobial susceptibility patterns, risk factors and their impact on mortality in cancer patients at a tertiary care cancer hospital- A prospective study.调查三级癌症医院癌症患者的抗菌药物敏感性模式、风险因素及其对死亡率的影响——一项前瞻性研究。
Ann Clin Microbiol Antimicrob. 2024 Jun 26;23(1):59. doi: 10.1186/s12941-024-00703-5.
3
Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin Plus Etoposide Therapy.小细胞肺癌患者接受卡铂联合依托泊苷治疗后发生发热性中性粒细胞减少症的危险因素分析。
Oncology. 2024;102(7):565-573. doi: 10.1159/000535822. Epub 2023 Dec 29.
4
Neutropenic Enterocolitis: An Uncommon, but Fearsome Complication of Leukemia.中性粒细胞减少性小肠结肠炎：白血病一种罕见但可怕的并发症。
J Hematol. 2023 Apr;12(2):59-65. doi: 10.14740/jh1105. Epub 2023 Apr 30.
5
Association Between the Neutrophil-to-Lymphocyte Ratio and Infection and Survival in Diffuse Large B Cell Lymphoma.中性粒细胞与淋巴细胞比值与弥漫性大 B 细胞淋巴瘤感染和生存的关系。
In Vivo. 2023 Mar-Apr;37(2):948-954. doi: 10.21873/invivo.13167.
6
Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern.新冠疫情时代患有癌症和发热性中性粒细胞减少症的老年患者：一个新的关注点。
J Geriatr Oncol. 2020 Nov;11(8):1329-1330. doi: 10.1016/j.jgo.2020.06.021. Epub 2020 Jun 18.

本文引用的文献

1
Optimal Management of Neutropenic Fever in Patients With Cancer.癌症患者中性粒细胞减少性发热的最佳管理。
J Oncol Pract. 2019 Jan;15(1):19-24. doi: 10.1200/JOP.18.00269.
2
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.成人癌症相关免疫抑制患者的抗菌预防：ASCO 和 IDSA 临床实践指南更新。
J Clin Oncol. 2018 Oct 20;36(30):3043-3054. doi: 10.1200/JCO.18.00374. Epub 2018 Sep 4.
3
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.癌症相关免疫抑制成年患者的抗菌药物预防：美国临床肿瘤学会（ASCO）和美国感染病学会（IDSA）临床实践指南更新摘要
J Oncol Pract. 2018 Nov;14(11):692-695. doi: 10.1200/JOP.18.00366. Epub 2018 Sep 4.
4
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.成人恶性肿瘤患者发热伴中性粒细胞减少的门诊管理：美国临床肿瘤学会和美国传染病学会临床实践指南更新摘要
J Oncol Pract. 2018 Apr;14(4):250-255. doi: 10.1200/JOP.18.00016. Epub 2018 Mar 8.
5
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.成人恶性肿瘤患者发热与中性粒细胞减少的门诊管理：美国临床肿瘤学会与感染病学会临床实践指南更新
J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.
6
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.抗菌药物在肿瘤中性粒细胞减少患者应用的临床实践指南：美国传染病学会 2010 年更新版。
Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.
7
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.成年癌症患者发热性中性粒细胞减少症相关的死亡率、发病率和成本
Cancer. 2006 May 15;106(10):2258-66. doi: 10.1002/cncr.21847.
8
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.癌症支持治疗多国协会风险指数：一种用于识别低风险发热性中性粒细胞减少癌症患者的多国评分系统。
J Clin Oncol. 2000 Aug;18(16):3038-51. doi: 10.1200/JCO.2000.18.16.3038.
9
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.
J Clin Oncol. 1992 Feb;10(2):316-22. doi: 10.1200/JCO.1992.10.2.316.